Health Outcomes | n (%) | Anti-inflammatory diet, OR (95%CI) | P for trend | |||
---|---|---|---|---|---|---|
Q1 (n = 2703) | Q2 (n = 2670) | Q3 (n = 2553) | Q4 (n = 3197) | |||
Crude moedl | Â | Â | Â | Â | Â | Â |
   Cognitive impairment | 2306 (20.73) | 1.88 (1.65–2.13) | 1.41 (1.23–1.61) | 1.34 (1.17–1.54) | 1.00 (Reference) | < 0.001 |
   Physical dysfunction | 2775 (24.95) | 1.35 (1.20–1.52) | 1.19 (1.06–1.35) | 1.12 (0.99–1.26) | 1.00 (Reference) | < 0.001 |
   Depressive symptoms | 1794 (16.13) | 1.69 (1.47–1.95) | 1.33 (1.15–1.54) | 1.17 (1.01–1.36) | 1.00 (Reference) | < 0.001 |
   Multimorbidity | 1792 (16.11) | 1.79 (1.55–2.06) | 1.39 (1.20–1.61) | 1.25 (1.08–1.45) | 1.00 (Reference) | < 0.001 |
Adjusted model | Â | Â | Â | Â | Â | Â |
   a Cognitive impairment | 2306 (20.73) | 1.41 (1.21–1.64) | 1.19 (1.02–1.38) | 1.18 (0.99–1.36) | 1.00 (Reference) | < 0.001 |
   b Physical dysfunction | 2775 (24.95) | 1.23 (1.06–1.42) | 1.15 (1.01–1.32) | 1.08 (0.94–1.24) | 1.00 (Reference) | 0.006 |
   b Depressive symptoms | 1794 (16.13) | 1.19 (1.01–1.40) | 1.07 (0.91–1.26) | 1.06 (0.90–1.24) | 1.00 (Reference) | 0.025 |
   b Multimorbidity | 1792 (16.11) | 1.33 (1.12–1.58) | 1.28 (1.08–1.51) | 1.05 (0.89–1.25) | 1.00 (Reference) | 0.002 |